Response to bortezomib in newly diagnosed multiple myeloma- a single centre experience from India

被引:0
|
作者
Rajan, V. [1 ]
N, G. [1 ]
Nair, S. G. [1 ]
机构
[1] Reg Canc Ctr Thiruvananthapuram Trivandrum, Med Oncol, Thiruvananthapuram, Kerala, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
305P
引用
收藏
页码:90 / 90
页数:1
相关论文
共 50 条
  • [21] The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma
    He, Jingsong
    Yang, Li
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Li, Li
    Zhang, Jie
    Huang, Weijia
    Zhao, Yi
    Huang, He
    Zhang, Xuejin
    Fu, Jiaping
    Cai, Zhen
    [J]. PLOS ONE, 2014, 9 (06):
  • [22] Single centre experience with bortezomib second line and beyond for myeloma
    Collins, A.
    Mattishent, K.
    Sadullah, S.
    Gomez, C.
    Braithwaite, J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 49 - 49
  • [23] Higher single dose of bortezomib plus thalidomide and dexamethasone is a promising therapy for newly diagnosed multiple myeloma
    Xu, Peipei
    Zhou, Rongfu
    Xu, Jingyan
    Ouyang, Jian
    Shao, Xiaoyan
    Chen, Bing
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 (05) : 2099 - 2106
  • [24] Autologous Stem Cell Transplantation for Multiple Myeloma: Single Centre Experience from North India
    Malhotra, Pankaj
    Yanamandra, Uday
    Khadwal, Alka
    Prakash, Gaurav
    Lad, Deepesh
    Law, Arjun D.
    Khurana, Harshit
    Sachdeva, M. U. S.
    Bose, Praveen
    Das, Reena
    Varma, Neelam
    Varma, Subhash
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (02) : 261 - 267
  • [25] Autologous Stem Cell Transplantation for Multiple Myeloma: Single Centre Experience from North India
    Pankaj Malhotra
    Uday Yanamandra
    Alka Khadwal
    Gaurav Prakash
    Deepesh Lad
    Arjun D. Law
    Harshit Khurana
    M. U. S. Sachdeva
    Praveen Bose
    Reena Das
    Neelam Varma
    Subhash Varma
    [J]. Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 261 - 267
  • [26] Bortezomib plus Thalidomide in Newly Diagnosed Myeloma
    Chen, S.
    Wang, L.
    Jiang, B.
    Qiu, L.
    Li, Y.
    Zhong, Y.
    Gao, W.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S62 - S63
  • [27] THE CHOICE OF REGIMENS BASED OF BORTEZOMIB FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: EXPERIENCES FROM CHINA
    Cai, Z.
    He, J.
    Yang, L.
    Han, X.
    Zheng, G.
    Zheng, W.
    Wei, G.
    Wu, W.
    Ye, X.
    Shi, J.
    Xie, W.
    Li, L.
    Zhang, J.
    Huang, W.
    Huang, H.
    Zhang, X.
    Fu, J.
    [J]. HAEMATOLOGICA, 2013, 98 : 607 - 607
  • [28] Clinical and laboratory features of newly diagnosed multiple myeloma:a retrospective,single-centre analysis
    MAI Yu-jie QI Pei-jing XU Yan ZOU De-hui WANG Ya-fei ZHAO Yao-zhong YANG Ren-chi XIAO Zhi-jian QIU Lu-gui Institute of Hematology & Blood Disease Hospital
    [J]. 中华医学杂志(英文版), 2007, (19) : 1727 - 1729
  • [29] Clinical and laboratory features of newly diagnosed multiple myeloma: a retrospective, single-centre analysis
    Mai Yu-jie
    Qi Pei-jing
    Xu Yan
    Zou De-hui
    Wang Ya-fei
    Zhao Yao-zhong
    Yang Ren-chi
    Xiao Zhi-jian
    Qiu Lu-gui
    [J]. CHINESE MEDICAL JOURNAL, 2007, 120 (19) : 1727 - 1729
  • [30] Clinical and laboratory features of newly diagnosed multiple myeloma:a retrospective,single-centre analysis
    MAI Yujie QI Peijing XU Yan ZOU Dehui WANG Yafei ZHAO Yaozhong YANG Renchi XIAO Zhijian QIU Lugui Institute of Hematology Blood Disease HospitalChinese Academy of Medical Sciences Peking Union of Medical CollegeTianjin China Mai YJ Qi PJ Xu Y Zou DH Wang YF Zhao YZ Yang RC Xiao ZJ Qiu LG MAI Yujie currently works at the Department of HematologyZhongshan Hospital of Dalian UniversityDalian Liaoning ProvinceChina
    [J]. ChineseMedicalJournal., 2007, 120 (19) - 1729